A year ago, Harvard Bioscience was on the fast track to growth. The company was growing revenues and expanding its reach through a series of acquisitions that created a diverse portfolio of companies providing tools to basic research, the clinical market, and drug discovery.

The stock price of the Holliston, Mass.-based laboratory equipment company grew to a high of $10.73 on Feb. 18, 2004, from a low of $3.00 on April 10, 2003.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.